AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 18 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,163 | +26.5% | 53,365 | +59.8% | 0.00% | – |
| Q2 2023 | $572,587 | +136555.6% | 33,387 | +60.6% | 0.00% | – |
| Q1 2023 | $419 | -88.4% | 20,792 | -83.1% | 0.00% | -100.0% |
| Q4 2022 | $3,610 | -99.7% | 123,208 | +47.3% | 0.00% | +100.0% |
| Q3 2022 | $1,387,000 | +268.9% | 83,630 | +247.5% | 0.00% | – |
| Q2 2022 | $376,000 | -74.4% | 24,066 | -65.6% | 0.00% | -100.0% |
| Q3 2021 | $1,466,000 | -1.3% | 69,867 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $1,485,000 | – | 65,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |